Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice

SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosey, Henry, Núñez, Juan A., Goring, Alice, Clarkin, Claire E., Staines, Katherine A., Lee, Peter D., Pitsillides, Andrew A., Javaheri, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769812/
https://www.ncbi.nlm.nih.gov/pubmed/29349060
http://dx.doi.org/10.3389/fmats.2017.00027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769812/
https://www.ncbi.nlm.nih.gov/pubmed/29349060
http://dx.doi.org/10.3389/fmats.2017.00027

Ejemplares similares